首页> 美国卫生研究院文献>BMJ Open >Original research: Use of the Aptima mRNA high-risk human papillomavirus (HR-HPV) assay compared to a DNA HR-HPV assay in the English cervical screening programme: a decision tree model based economic evaluation

【2h】

Original research: Use of the Aptima mRNA high-risk human papillomavirus (HR-HPV) assay compared to a DNA HR-HPV assay in the English cervical screening programme: a decision tree model based economic evaluation

机译：原始研究：在英语宫颈癌筛查计划中将Aptima mRNA高危人类乳头瘤病毒（HR-HPV）分析与DNA HR-HPV分析相比的使用：基于决策树模型的经济评估

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

To estimate the impact of using the Aptima messenger RNA (mRNA) high-risk human papilloma virus (HR-HPV) assay versus a DNA HR-HPV assay in a primary HPV cervical screening programme.

机译：为了评估在初级HPV子宫颈筛查程序中使用Aptima信使RNA（mRNA）高风险人乳头瘤病毒（HR-HPV）分析与DNA HR-HPV分析的影响。

著录项

期刊名称 BMJ Open
作者
Georgie Weston; Caroline Dombrowski; Michael J Harvey; Thomas Iftner; Maria Kyrgiou; Christina Founta; Elisabeth J Adams;
展开▼
作者单位

展开▼
年(卷),期 2020(10),3
年度 2020
页码 -1
总页数 10
原文格式 PDF
正文语种
中图分类
关键词
colposcopy; health economics; gynaecological oncology; microbiology; public health;

机译：阴道镜;卫生经济学;妇科肿瘤学;微生物学;公共卫生;

相似文献

外文文献
中文文献

1. Diagnostic performance of the E6/E7 mRNA-based Optimygene HR-HPV RT-qDx assay for cervical cancer screening [J] . Hye-young Wang, Hyunil Kim, Kwang Hwa Park International journal of infectious diseases : . 2019,第3S1期

机译：基于E6 / E7 mRNA的诊断性能的宫颈癌筛查的e6 / E7 mRNA优化糖尿病HR-HPV RT-QDX测定
2. Cervical cancer screening in north east Thailand using the visual inspection with acetic acid (VIA) test and its relationship to high-risk human papillomavirus (HR-HPV) status. [J] . Ekalaksananan T, Pientong C, Thinkhamrop J, The journal of obstetrics and gynaecology research . 2010,第5期

机译：在泰国东北部使用乙酸（VIA）目测进行宫颈癌筛查及其与高危人类乳头瘤病毒（HR-HPV）状况的关系。
3. Aptima assay for High-Risk Human Papillomavirus Shows Higher Specificity and Better Correlation to Pap Smears Compared to Cervista Assay [J] . Lindeman T. L., Edwards K. L., Sizemore J., The Journal of molecular diagnostics: JMD . 2014,第6期

机译：与宫颈癌相比，高危人乳头瘤病毒的Aptima检测显示更高的特异性和与宫颈涂片的更好相关性
4. Study on Screening Cervical Precancerous Lesions by High-risk Human Papillomavirus DNA Detection and Cytological Examination [C] . Lingling Tong, Xiaojun Liu International Conference on Biomedical Sciences and Information Systems;Hebei University of Science and Technology . 2019

机译：高危人乳头瘤病毒DNA检测及细胞学检查筛查宫颈癌前病变的研究
5. Longitudinal Clinical Performance of the RNA-Based Aptima Human Papillomavirus (AHPV) Assay in Comparison to the DNA-Based Hybrid Capture 2 HPV Test in Two Consecutive Screening Rounds with a 6-Year Interval in Germany [O] . Thomas Iftner, Klaus-Joachim Neis, Alejandra Castanon, 2019

机译：在德国进行的连续两次筛选周期（间隔为6年）中基于RNA的Aptima人乳头瘤病毒（AHPV）检测与基于DNA的Hybrid Capture 2 HPV检测的纵向临床表现
6. Use of the Aptima mRNA high-risk human papillomavirus (HR-HPV) assay compared to a DNA HR-HPV assay in the English cervical screening programme: a decision tree model based economic evaluation [O] . Georgie Weston, Caroline Dombrowski, Michael J Harvey, 2020

机译：与英语宫颈筛查计划中的DNA HR-HPV测定相比，使用APTIMA mRNA高风险的人乳头瘤病毒（HR-HPV）测定：基于决策树模型的经济评估

Original research: Use of the Aptima mRNA high-risk human papillomavirus (HR-HPV) assay compared to a DNA HR-HPV assay in the English cervical screening programme: a decision tree model based economic evaluation

摘要

著录项

相似文献

相关主题

期刊订阅